|

AK130 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 2

Top Sponsors

  • Akeso3

Indications

  • Cancer3
  • Liver Disease1
  • Biliary Tract Cancer1
  • Pancreatic Cancer1
  • Liver Cancer1

Other3 trials

A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Phase 1/2
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer
Phase 1/2
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.